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Summary
The Drosophila host defense against gram-negative
bacteria is mediated by the Imd pathway upon sensing
of peptidoglycan by the peptidoglycan recognition
protein (PGRP)-LC. Here we report a functional anal-
ysis of PGRP-LB, a catalytic member of the PGRP
family. We show that PGRP-LB is a secreted protein
regulated by the Imd pathway. Biochemical studies
demonstrate that PGRP-LB is an amidase that specifi-
cally degrades gram-negative bacteria peptidoglycan.
In agreement with its amidase activity, PGRP-LB
downregulates the Imd pathway. Hence, activation of
PGRP-LB by the Imd pathway provides a negative
feedback regulation to tightly adjust immune activa-
tion to infection. Our study also reveals that PGRP-
LB controls the immune reactivity of flies to the
presence of ingested bacteria in the gut. Our work
highlights the key role of PGRPs that encode both sen-
sors and scavengers of peptidoglycan, which modu-
late the level of the host immune response to the pres-
ence of infectious microorganisms.
Introduction
Drosophila is devoid of an adaptive immune system and
relies solely on innate immune reactions for its defense
(Kaneko et al., 2005; Royet et al., 2005). One of the key
features of the Drosophila immune response is the syn-
thesis of several antimicrobial peptides (AMPs) with dis-
*Correspondence: lemaitre@cgm.cnrs-gif.frtinct but overlapping specificities by the fat body, an
equivalent of the mammalian liver. AMPs are secreted
into the hemolymph, where they directly kill invading mi-
croorganisms. Genetic analyses show that AMP genes
are regulated by the Toll and Imd pathways. These two
pathways share many common features with the mam-
malian TLR and TNF-a (tissue necrosis factor) signaling
cascades that regulate NF-kB transcription factors. The
Toll pathway is triggered by the proteolytic cleavage of
the Toll ligand, the cytokine Spatzle (Spz), and leads to
activation of the Rel proteins Dif and Dorsal. This path-
way is activated by both gram-positive bacteria and
fungi and controls to a large extent the expression of
AMPs active against fungi (e.g., Drosomycin). In con-
trast, the Imd pathway mainly responds to gram-nega-
tive bacterial infection and controls antibacterial peptide
genes (e.g., Diptericin) via the activation of the Rel pro-
tein Relish.
In Drosophila, bacterial recognition is achieved
through the sensing of specific forms of peptidoglycan
(PGN) by peptidoglycan recognition proteins (PGRPs).
PGN is an essential and specific polymer of the cell
wall of both gram-negative and gram-positive bacteria.
It consists of long glycan chains made of alternating
N-acetylglucosamine and N-acetylmuramic acid resi-
dues that are crosslinked to each other by short peptide
bridges (Mengin-Lecreulx and Lemaitre, 2005). PGN
from gram-negative bacteria differs from most gram-
positive PGN by the replacement of lysine with meso-
diaminopimelic acid (DAP) at the third position in the
peptide chain. PGRPs are proteins that bind to and in
some cases hydrolyze PGN. These molecules are highly
conserved from insects to mammals and share a con-
served 160 amino acid domain with similarities to the
bacteriophage T7 lysozyme, a zinc-dependent N-acetyl-
muramoyl-L-alanine amidase (Royet et al., 2005;
Steiner, 2004). Sequence analysis of the 13 Drosophila
PGRPs points to the existence of two subgroups with ei-
ther recognition or catalytic properties. The first group
(PGRP-SA, SD, LA, LC, LD, LE, LF) lacks zinc binding
residues required for amidase activity but still retains
the ability to bind and recognize PGN. PGRP-SA and
PGRP-SD are secreted proteins circulating in the hemo-
lymph that have been shown to activate the Toll pathway
in response to lysine-type PGN found in most gram-
positive bacteria (Royet et al., 2005; Steiner, 2004).
PGRP-LC acts as a transmembrane receptor upstream
of the Imd pathway and is activated by the DAP-type
PGN of gram-negative bacteria (Royet et al., 2005;
Steiner, 2004). Recent studies indicate that both poly-
meric and monomeric gram-negative PGN mediate
Imd pathway activation via various PGRP-LC isoforms
(Kaneko et al., 2004; Mellroth et al., 2005; Stenbak
et al., 2004). Finally, PGRP-LE, a secreted PGRP that
binds preferentially to DAP-type PGN, functions syner-
gistically with PGRP-LC in Imd pathway activation
(Takehana et al., 2004). In contrast, another subgroup
of PGRPs referred to as catalytic PGRPs have demon-
strated (PGRP-SC1A/B) or predicted (PGRP-LB, SB1/
2, SC2) zinc-dependent amidase activity that removes
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eliminating the biological activity of PGN (Mellroth
et al., 2003). The exact in vivo functions of catalytic
PGRPs are not known, although their amidase activity
has led to the proposal that they could either modulate
the immune response by scavenging PGN or act directly
as antibacterial factors (Mellroth et al., 2003). Therefore,
we decided to perform an extensive biochemical and
genetic analysis of PGRP-LB, a catalytic PGRP.
Results
PGRP-LB Is a Secreted PGRP Regulated
by the Imd Pathway
Oligonucleotide microarray analysis performed on Dro-
sophila adult males indicated that the gene PGRP-LB
is induced 7-fold following septic injury (De Gregorio
et al., 2002). The comparison of PGRP-LB mRNA
profiles in wild-type and mutant flies deficient for Toll
(spatzle; spz) or Imd (Relish; Rel) signaling revealed
that PGRP-LB expression is controlled by the Imd path-
way (Figure 1A). Time course analysis of the expression
profile of PGRP-LB during the Drosophila immune re-
sponse was performed with protein extracts from male
adult flies collected at different time intervals following
septic injury with gram-negative Erwinia carotovora
(Figure 1B). Western blot analysis illustrates that
PGRP-LB expression was weak in unchallenged adult
males, whereas expression levels increased by 3 hr post-
challenge reaching a plateau at 22 hr. PGRP-LB was
abundant in protein extracts derived from the hemo-
lymph (Figure 1C) and the fat body, the major immune-
responsive tissue (data not shown). This indicates that
PGRP-LB is produced by the fat body and secreted
into the hemolymph. TheDrosophila genome annotation
predicts the existence of two PGRP-LB isoforms of 216
and 232 amino acids, respectively, differing by the pres-
ence or absence of a predicted N-terminal signal pep-
tide. This is consistent with the observation of two forms
of PGRP-LB in total fly extracts. In agreement with the
mRNA analysis (Figure 1A), PGRP-LB was not induced
by septic injury in Rel mutant flies lacking a functional
Imd pathway (Figure 1D). Altogether, these results indi-
cate that stimulation of the Imd pathway by gram-nega-
tive bacteria leads to the rapid synthesis and secretion of
PGRP-LB by the fat body into the hemolymph.
PGRP-LB Is an Amidase Specific of DAP-Type PGN
To determine the role of PGRP-LB, we first undertook
a biochemical approach. Recombinant PGRP-LB was
previously shown to bind purified PGN from various
bacterial species but did not exhibit any bactericidal ac-
tivity against gram-negative or gram-positive bacteria
(Kim et al., 2003). However, PGRP-LB induces lysis of
sensitized (EDTA-treated) E. coli cells, suggesting a
PGN-hydrolyzing activity. More precisely, an N-acetyl-
muramoyl-L-alanine amidase activity was suspected,
based on sequence homologies of PGRP-LB and cata-
lytic PGRPs such as PGRP-SC1B with the T7 lysozyme
(Mellroth et al., 2003). We therefore analyzed in more de-
tail the enzymatic properties and substrate specificity of
PGRP-LB. Incubation of pure PGN from E. coli with re-
combinant PGRP-LB resulted in a rapid and almostcomplete release of the tetrapeptide L-Ala-g-D-Glu-
meso-DAP-D-Ala and of its octapeptide dimer from the
macromolecule, confirming a strong PGN-hydrolyzing
amidase activity (Figures 2A and 2B). Under standard
assay conditions, the specific enzymatic activity de-
tected on the whole PGN polymer was very high, w4.6
mmol.min21.mg21. As a control, we produced a mutated
form of PGRP-LB in which the cysteine 160 is sub-
stituted with a serine. In catalytic PGRPs, Cys160 is
a conserved residue, which coordinates the zinc ion re-
quired for amidase activity. The C160S mutant did not
show any amidase activity (data not shown).
An anhydro form of MurNAc occurs naturally in gram-
negative bacteria at the extremity of all glycan strands
and is consequently present in approximately 5% of
the GlcNAc-MurNAc units (Figure 2A). The GlcNAc-
MurNAc(anhydro)-L-Ala-g-D-Glu-meso-DAP-D-Ala mono-
mer, also known as tracheal cytotoxin (TCT), was previ-
ously identified as the minimum PGN motif capable of
efficiently inducing the Imd pathway (Kaneko et al.,
2004; Stenbak et al., 2004). TCT provides an ideal ‘‘sig-
nature’’ of gram-negative bacteria, since this muropep-
tide is continuously released from PGN during cell
Figure 1. Expression Profile of PGRP-LB after Septic Injury
(A) The gene expression profile for PGRP-LB shows rapid induction
at 1.5 hr, followed by sustained expression at later time points. A
mutation affectingRel, but not a mutation in spz, encoding the ligand
of the Toll receptor, inhibited the expression ofPGRP-LB after infec-
tion, demonstrating that the gene is under the control of the Imd
pathway. The microarray data for this figure were extracted from
De Gregorio et al. (2002). (B) This time course analysis shows that
PGRP-LB expression is induced upon immune challenge. Two iso-
forms of about 29 and 30 kDa were detected by a mouse antiserum
directed against recombinant PGRP-LB. Western blot analysis was
performed with protein extracts from male wild-type flies collected
at different time points after infection. (C) PGRP-LB is secreted
into the hemolymph. Western blot analysis was performed with he-
molymph samples extracted from female wild-type flies collected at
16 hr postinfection. The absence of a signal with a-tubulin (a-Tub)
antibody indicates that the hemolymph preparations are not con-
taminated by cells. (D) PGRP-LB is not induced upon immune chal-
lenge inRel-deficient flies. The blots obtained in independent exper-
iments were probed with both a polyclonal anti-PGRP-LB (upper
panel) and an anti-a-Tub antibody (lower panel). Wild-type (wt) flies
were da-GAL4/+ (B and C) or OregonR (A and D). SI, septic injury by
E. carotovora. C, unchallenged control flies.
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Specificity of PGRP-LB
(A) Structure of E. coli PGN (DAP-type) indi-
cating the cleavage sites for theN-acetylmur-
amoyl-L-alanine amidase activity of PGRP-
LB (plain arrows). The main peptides released
following treatment of crosslinked PGN with
PGRP-LB are the tetrapeptide L-Ala-g-D-
Glu-meso-DAP-D-Ala (1) and its dimer, the
octapeptide (2). Glycan chains of E. coli
PGN all end with a 1,6-anhydro-MurNAc res-
idue, and the terminal disaccharide-tetrapep-
tide motif corresponds to the structure of TCT
(3). Both lytic transglycosylases and murami-
dases catalyze the cleavage of the b-1,4-gly-
cosidic bond between the MurNAc and
GlcNAc residues (dashed arrows). However,
the bacterial transglycosylases catalyze an
additional intramolecular transglycosylation
reaction that results in the formation of a
1,6-anhydro MurNAc residue.
(B) HPLC analysis of soluble peptides re-
leased following digestion of E. coli PGN by
PGRP-LB. Purified PGN (150 mg) was incu-
bated for 30 min at 37ºC with 0.5 mg of
PGRP-LB protein. Peaks corresponding to
the tetrapeptide and octapeptide are indi-
cated by 1 and 2, respectively.
(C) The substrate specificity of PGRP-LB was
determined by measuring its amidase activity
on a series of muropeptides representing var-
iations in the composition (DAP- or lysine-
type) or length (one to five amino acid resi-
dues) of the peptide moiety. Muropeptides
were tested at 0.125 mM in standard assay
conditions, and substrate and products were
separated by HPLC.
(D) A Western blot experiment shows that
PGRP-LB was detected in wild-type but not
in PGRP-LB RNAi flies collected 16 hr after
bacterial injection. (3) and (1) represent two
independent PGRP-LB IR insertions.
(E) The amidase activity of hemolymph sam-
ples collected from wild-type and PGRP-LB
RNAi flies was monitored by HPLC after injec-
tion of [14C]DAP-radiolabeled TCT dimer.
[14C] TCT dimer was injected in unchallenged flies (top) or flies collected 22 hr after a bacterial challenge (bottom) and extracted for analysis
20 min later. Peak 1, octapeptide (cleavage at both I and II sites); peak 2, TCT-octapeptide (cleavage at either I or II); peak 3, TCT dimer substrate.
The radioactivity detected in peaks of these different compounds is indicated as a percentage of the total radioactivity.growth and division. Figure 2C shows that the specific
activity of PGRP-LB on TCT was quite similar to that ob-
served on the macromolecule.
In order to more precisely define the substrate speci-
ficity of PGRP-LB, a series of muropeptides derived
from the PGN structure were tested (Figure 2C). Varying
the length and composition of the peptide moiety
showed that PGRP-LB requires at least a tripeptide for
activity, since no cleavage of MurNAc-L-Ala was detect-
able, and that cleavage of MurNAc-L-Ala-D-Glu oc-
curred at a rate 104-fold lower compared to its tri- to
pentapeptide derivatives. Furthermore, replacement of
meso-DAP by L-lysine (as is the case in the PGN of
most gram-positive species) resulted in a dramatic
decrease of PGRP-LB activity, by factors ranging from
102 to 103. This finding is in agreement with the poor
activity exhibited by PGRP-LB on PGN purified from
gram-positive Micrococcus luteus, as compared to
that of gram-negative E. coli (data not shown). This bio-
chemical analysis demonstrates that PGRP-LB is anefficient amidase that degrades gram-negative PGN
into non-immuno-stimulatory fragments.
Hemolymph of PGRP-LB RNAi Flies Exhibits
Reduced Amidase Activity
We next analyzed the role of PGRP-LB in vivo using an
inducible RNA interference (RNAi) strategy. We gener-
ated transgenic flies carrying the UAS-PGRP-LB In-
verted Repeat element (referred to as PGRP-LB IR). In
order to activate transcription of the hairpin-encoding
transgene in the progeny (referred to as PGRP-LB
RNAi flies), these transgenic flies were crossed with flies
carrying the daughterless (da)-GAL4 driver expressing
GAL4 strongly and ubiquitously.
PGRP-LB RNAi animals showed significant lethality at
the pupal stage when raised at 29ºC. PGRP-LB RNAi
adult escapers raised at 25ºC were, however, viable
and showed no visible difference to wild-type flies. We
confirmed that the PGRP-LB protein was almost unde-
tectable in samples from infected PGRP-LB RNAi adults
Immunity
466(Figure 2D), whereas expression of other amidase
PGRPs (SB1, SC2, SC1) was not reduced (see Figure S1
in the Supplemental Data available with this article on-
line). In order to correlate in vitro and in vivo analyses,
we compared the amidase activity in hemolymph of
PGRP-LB RNAi flies to wild-type flies. [14C]DAP-radiola-
beled TCT dimer was injected into unchallenged flies
and flies collected 16 hr after septic injury. HPLC analy-
sis of soluble radiolabeled compounds from hemolymph
samples collected at 20 min postinjection shows that
TCT dimer was rapidly digested into free octapeptide
(dimer of L-Ala-g-D-Glu-meso-DAP-D-Ala, Figure 2E,
peak 1), consistent with an amidase-type activity at the
two cleavage sites (I and II) present in the TCT dimer
(Figure 2E). An intermediate product corresponding to
TCT-octapeptide (Figure 2E, peak 2) was observed
that results from cleavage at only one of the two sites.
This result indicates the existence of a strong amidase
activity in the hemolymph of wild-type flies. A bacterial
challenge increased the amidase activity of the hemo-
lymph in wild-type flies, consistent with our observation
that amidase PGRPs are upregulated by infection. Inter-
estingly, digestion of TCT dimer was greatly reduced in
both unchallenged and bacteria-challenged PGRP-LB
RNAi flies, indicating a significant decrease in hemo-
lymph amidase activity. At 90 min postinjection, diges-
tion of TCT dimer was complete in wild-type samples
and almost complete in PGRP-LB RNAi samples col-
lected from noninfected flies (data not shown). The am-
idase activity detected in the latter extracts could be due
to the presence of other catalytic PGRPs and/or to a
residual level of PGRP-LB, since RNAi mimics a hypo-
morphic mutation. This study demonstrates that flies
exhibit strong hemolymph amidase activity that hydro-
lyzes PGN into nonstimulatory fragments and that
PGRP-LB contributes to this activity in vivo.
PGRP-LB Negatively Regulates the Imd Pathway
Following Gram-Negative Bacterial Injection
The expression profile and activity of PGRP-LB strongly
suggested a function in the immune response against
gram-negative bacteria. In order to clarify its role, we an-
alyzed the effect of PGRP-LB reduction on the systemic
immune response induced upon injection of different
classes of microorganisms into the hemolymph of
PGRP-LBRNAi flies. Inactivation of PGRP-LB did not in-
duce increased susceptibility to infection (Figure 3A,
data not shown), as determined from fly survival rates
following injection of E. carotovora, whereas inhibition
of the Imd pathway in a Relmutant had a dramatic effect
upon survival (Hedengren et al., 1999). Consistent with
this observation, both Diptericin (Dpt) and Drosomycin
(Drs) gene expression remained inducible in PGRP-LB
RNAi flies (see below), indicating that PGRP-LB does
not function as a recognition receptor upstream of Toll
or the Imd pathway.
Interestingly, a time course analysis ofDpt expression
following septic injury with gram-negative bacteria re-
vealed a stronger immune response in PGRP-LB RNAi
flies compared to wild-type flies (Figure 3B). Indeed,
whereas the levels of Dpt were similar between 3 and 6
hr postchallenge, they were 1.5- to 2-fold higher in
PGRP-LB RNAi flies at later time points. The same phe-
notype was observed when flies were injected with con-centrated solutions of either gram-negative PGN or TCT
instead of live bacteria (Figures 3C and 3D, respec-
tively). Since PGN and TCT are inert compounds, this re-
sult indicates that the stronger Dpt expression in PGRP-
LB RNAi flies after gram-negative bacteria injection was
not due to a difference in bacterial proliferation but
resulted from an increase in Imd signaling stimulation.
To demonstrate that the stronger Dpt expression was
indeed due to a lack of PGRP-LB, we performed a rescue
experiment using a recombinant PGRP-LB protein.
Figure 3. Role of PGRP-LB during the Systemic Response to Septic
Injury
(A) A survival analysis shows that PGRP-LB RNAi flies were resistant
to gram-negative bacterial infection. Survival tests were performed
at 29ºC with 60 flies each, and the numbers of surviving flies were
counted at different time points after challenge with E. carotovora.
(B–D) PGRP-LB downregulates the Imd pathway after gram-nega-
tive bacterial infection. Time course analysis of Dpt gene expression
in wild-type and PGRP-LB RNAi flies after septic injury with E. caro-
tovora (B) or injection of gram-negative bacterial PGN (C) or TCT (D).
RT-qPCR analyses were performed on total RNA extracts from wild-
type and PGRP-LB RNAi female flies collected at different time
points after injection of E. carotovora, P. aeruginosa PGN or TCT.
(E) Injection of recombinant PGRP-LB (rPGRP-LB) restored a wild-
type level ofDpt expression inPGRP-LBRNAi flies (left panel). Water
(23 nl) or rPGRP-LB ([rPGRP-LB] = 1 mg.ml21) was injected into wild-
type or PGRP-LB RNAi flies 1 hr prior to the injection of P. aerugi-
nosa PGN. Note that injection of rPGRP-LB reduced the induction
of Dpt in wild-type flies. RT-qPCRs were performed on flies col-
lected 6 hr postchallenge. Injection of PGRP-LB C160S ([rPGRP-
LB C160S] = 1 mg.ml21) did not reduce the level of Dpt expression
in PGRP-LB RNAi flies (right panel). (C–E) PGN (9 nl) ([PGN] = 5
mg.ml21) or TCT ([TCT] = 0.46 mM) was injected in flies. Repeats
and statistics for experiments described in (B)–(E) are provided in
Figure S3.
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(A) Oral bacterial infection induced PGRP-LB in the gut of wild-type
but not Rel flies. A Western blot was performed on gut extracts de-
rived from flies fed for 20 hr with E. carotovora. An upper band (indi-
cated by a black arrow) that crossreacts with the anti-PGRP-LB
serum was used as a loading control. NI, natural infection. C, unchal-
lenged control.
(B) In contrast to wild-type larvae, most PGRP-LB RNAi larvae ex-
pressed the Drs-GFP reporter in the trachea under normal rearing
conditions. No Drs expression was observed in PGRP-LB/LC dou-
ble RNAi larvae, confirming that Drs-GFP expression in the trachea
is regulated by the Imd pathway. (Top panel) Drs-GFP; da-GAL4/
PGRP-LB IR. (Middle panel) Drs-GFP; da-GAL4/+. (Lower panel)
Drs-GFP; da-GAL4, PGRP-LB IR/PGRP-LC IR.
(C) Histochemical staining of b-galactosidase activity is observed
in the anterior midgut at the level of the proventriculus of mostFigure 3E shows that injection of PGRP-LB protein but
not the C106S mutant into the hemolymph of PGRP-
LB RNAi flies restores a wild-type expression level of
Dpt after injection of gram-negative PGN. Interestingly,
the expression level of Dpt after injection of gram-nega-
tive PGN was lowered in wild-type flies after a prior
injection of PGRP-LB (Figure 3E). This experiment
confirmed that PGRP-LB negatively regulates the Imd
pathway in agreement with its capacity to scavenge
gram-negative PGN.
Finally, we observed that PGRP-LB does not affect
Toll pathway activation by gram-positive bacteria, con-
sistent with the weak enzymatic activity PGRP-LB ex-
hibits toward lysine-type PGN (Figure S2).
PGRP-LB Downregulates the Imd Pathway
during Local Immune Response
In addition to the fat body, AMP genes can be expressed
in several surface epithelia, which are potentially in con-
tact with microorganisms (Tzou et al., 2000). Local ex-
pression of Dpt in the anterior midgut at the level of
the proventriculus andDrs in the trachea can be induced
by the Imd pathway upon natural infection by gram-neg-
ative bacteria such as E. carotovora.
We demonstrated by Western blot analysis that
PGRP-LB is induced in the digestive tract upon natural
bacterial infection in a Rel-dependent manner (Fig-
ure 4A). This observation prompted us to test a possible
implication of PGRP-LB in local AMP expression. The
use of reporter genes revealed that PGRP-LB inactiva-
tion by RNAi leads to higher AMP gene expression:
92% of PGRP-LB RNAi larvae but only 5% of wild-type
larvae expressed a Drs-GFP reporter gene in trachea
in the absence of an immune challenge (Figure 4B). Sim-
ilarly, almost all PGRP-LB RNAi larvae and adults ex-
pressed Dpt in the proventriculus under normal rearing
conditions (Figure 4C, data not shown for adults). These
observations indicate that PGRP-LB prevents the local
activation of the Imd pathway in the absence of patho-
genic micro-organisms. In the gut, PGRP-LB could in-
hibit Imd activation by hydrolyzing PGN fragments re-
leased by bacteria present in the digestive tract. To
date, the nature of the bacterial elicitor(s) and host re-
ceptor(s) implicated in local immunity has not yet been
investigated, and it was not known whether PGN could
indeed activate this response. To address this question,
we monitored the level of Dpt expression in the gut of
PGRP-LB RNAi larvae that carry the Dpt-lacZ reporter gene in ab-
sence of an infection. Similar results were obtained with a Dpt-
GFP reporter gene (right panel).
(D) Oral ingestion of gram-negative PGN but not gram-positive PGN
triggeredDpt-lacZ reporter gene expression in the proventriculus. b-
galactosidase stainings were performed on guts from wild-type and
PGRP-LC mutant flies carrying a Dpt-lacZ reporter gene. Flies were
fed during 20 hr with sucrose alone (C, control), sucrose mixed with
gram-positive PGN (M. luteus, M.l.), gram-negative PGN (P. aerugi-
nosa, P.a.), or E. carotovora. After E. carotovora feeding, no Dpt ex-
pression was observed in the gut of a PGRP-LCE12 mutant (far right
panel).
(E) Oral ingestion of gram-negative PGN triggered Dpt expression in
the gut. RT-qPCR was performed with gut extracts from wild-type
and PGRP-LB RNAi flies that were fed during 20 hr on sucrose (con-
trol), sucrose mixed with gram-positive PGN (M. luteus), gram-neg-
ative PGN (P. aeruginosa), or E. carotovora. This experiment was
repeated three times and yielded similar results.
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Both the use of a Dpt-lacZ reporter gene and RT-qPCR
show that Dpt was induced in the gut after ingestion of
gram-negative but not gram-positive PGN (Figures 4D
and 4E). The level ofDpt expression stimulated by gram-
negative PGN was, however, weaker than the level
induced after oral infection with E. carotovora. In agree-
ment with our hypothesis that PGRP-LB may prevent
Imd activation by hydrolyzing PGN fragments released
by bacteria, we noted that PGRP-LB RNAi flies dis-
played a higher Dpt expression after ingestion of gram-
negative PGN (Figure 4E).
We also observed that the induction of Drs in trachea
or Dpt in the gut was blocked in PGRP-LC deficient mu-
tants upon infection by E. carotovora (Figure 4D and
data not shown), indicating that PGRP-LC is involved
in this local activation of the Imd pathway. Consistent
with this observation, the higher local AMP gene expres-
sion in gut and trachea induced byPGRP-LBRNAi in ab-
sence of a challenge was suppressed by coexpression
of a PGRP-LC RNAi construct (Figure 4B and data not
shown).
Altogether, these data demonstrate that the local im-
mune response is mediated through the recognition of
gram-negative PGN by PGRP-LC and that PGRP-LB
plays an important role in epithelia by preventing local
immune activation in the absence of a severe infection.
PGRP-LB Prevents Systemic Immune Activation
after Ingestion of PGN
In addition to triggering a local response, the presence
of specific gram-negative bacterial species (e.g., P. en-
tomophila) in the gut can trigger a systemic immune re-
sponse in the fat body without bacterial invasion of the
hemolymph (Basset et al., 2000; Vodovar et al., 2005).
The signals that link the bacterial persistence in the
gut and Imd pathway activation in the fat body are pres-
ently unknown. Since PGRP-LB in the gut and in the
hemolymph influences the immune reactivity to gram-
negative bacteria, we investigated a possible role of
PGRP-LB in the modulation of this response. In agree-
ment with previous studies (Vodovar et al., 2005), oral in-
fection by P. entomophila triggered a strong expression
of Dpt in wild-type adult flies, whereas E. carotovora did
not (Figure 5A). However, both bacterial species in-
duced high levels of Dpt expression in PGRP-LB RNAi
flies (Figure 5A). The use of a lacZ reporter gene and
RT-qPCR experiments demonstrated that the Dpt
gene was expressed in the fat body of almost 50% of
PGRP-LB RNAi flies orally infected by E. carotovora
(Figure 5B, data not shown). Taking into account the en-
zymatic activity of PGRP-LB, we reasoned that this phe-
notype could be due to the absence of degradation of
the PGN released by the bacteria in the gut. PGN con-
centration would then increase, thus resulting in a fat
body response in PGRP-LB RNAi flies. To test this hy-
pothesis, we monitored systemic Dpt expression in
wild-type and PGRP-LB RNAi adults fed with gram-neg-
ative PGN. Figure 5C shows that oral ingestion of gram-
negative PGN induced a sustained expression of Dpt
expression in PGRP-LB RNAi but not in wild-type flies.
The level of Dpt in PGRP-LB RNAi flies was proportional
to the concentration of the PGN solution used to feed
the flies (Figure 5D). Figure 5D also illustrates that Dptinduction was not observed when flies were fed with
PGNs derived from various gram-positive bacteria.
This study shows that PGRP-LB participates in bacte-
rial tolerance by preventing the activation of a systemic
immune response by ingested bacteria.
Ingestion of TCT Induces a Potent Systemic
Response in PGRP-LB RNAi Flies
PGN polymers can be degraded by enzymes such as
muramidases or lysozymes, which catalyze the cleav-
age of the b-1,4 bond between MurNAc and GlcNAc in
glycan strands and generate muropeptides (Figure 2A).
Lysozymes, which are abundantly expressed in the gut
of Drosophila (Daffre et al., 1994), could process in-
gested PGN in small fragments thereby modulating its
immune activity. To address this question, we moni-
tored Dpt gene expression in PGRP-LB RNAi and wild-
type flies fed with intact or muramidase-digested PGN.
Figure 6A shows that the muramidase treatment in-
creased the ability of PGN to induce a systemic immune
response in PGRP-LB RNAi flies.
Figure 5. PGRP-LB Prevents the Systemic Immune Response after
Oral Infection of Bacteria
(A) Oral infection with P. entomophila and E. carotovora induced
strong Dpt expression in PGRP-LB RNAi flies, while Dpt was in-
duced only by P. entomophila in wild-type flies. Analysis was per-
formed on wild-type and PGRP-LB RNAi females collected 12 hr af-
ter oral bacterial infection. (B) Oral infection byE. carotovora triggers
a systemic immune response in PGRP-LB RNAi flies. A strong b-ga-
lactosidase staining was observed in the fat body of PGRP-LB RNAi
but not of wild-type flies carrying a Dpt-lacZ reporter gene. Car-
casses of flies were fixed and stained 20 hr after oral infection with
E. carotovora. (C) Ingestion of gram-negative PGN induces Dpt in
PGRP-LB RNAi flies. Time course analysis of Dpt gene expression
was performed on wild-type and PGRP-LB RNAi flies after ingestion
of P. aeruginosa PGN. (D) Ingestion of gram-negative but not gram-
positive PGN induces Dpt in PGRP-LB RNAi flies. Analysis was
performed on wild-type and PGRP-LB RNAi females fed 12 hr
with preparations of lysine-type PGN (Enterococcus faecalis, E.f.;
M. luteus, M.l.), DAP-type PGN from gram-positive Bacilli (Bacillus
subtilis, B.s.; Bacillus thuringiensis, B.t.), and gram-negative PGN
(P. aeruginosa, P.a.; E. coli, E.c.). Dilution of P. aeruginosa PGN re-
sults in proportionally lower Dpt expression. (A, C, and D) Dpt ex-
pression was monitored by RT-qPCR with RNA extracts from whole
flies. The levels measured in these experiments corresponded to
systemic expression of Dpt by the fat body, since the contribution
of gut to Dpt expression is negligible. Repeats and statistics for ex-
periments described in (A) and (C) are provided in Figure S4.
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469Figure 6. Ingestion of TCT Triggers Systemic Immune Response in
PGRP-LB RNAi Flies
(A) Ingestion of gram-negative PGN digested by either muramidase
or SltY increases Imd pathway activation. Female flies were fed with
muramidase-treated, SltY-treated, or untreated PGN from E. coli
([PGN] = 0.2 mg/mL).Dpt expression was monitored 12 hr postinfec-
tion. (B) Ingestion of TCT strongly induces Dpt in PGRP-LB RNAi
flies. Time course analysis of Dpt gene expression in male wild-
type and PGRP-LB RNAi flies after ingestion of TCT ([TCT] = 0.23
mM). (C) Dilution of TCT results in proportionally lower Dpt expres-
sion. Dpt expression was monitored in wild-type and PGRP-LB
RNAi male flies 12 hr after ingestion of serial dilutions of a solution
of TCT ([TCT] = 0.23 mM). (D) Dpt induction by TCT requires
PGRP-LC. Dpt expression was monitored in PGRP-LC RNAi,
PGRP-LB RNAi, and PGRP-LC/LB double RNAi flies fed for 12 hr
with TCT ([TCT] = 0.023 mM). (E) Use of fat body (c564, ppl), gut
(NP1), and hemocyte (pxn) GAL4 drivers indicates a requirement of
PGRP-LB in both gut and fat body. Dpt expression was monitored
in flies expressing PGRP-LB IR with the different GAL4 drivers after
12 hr of feeding with TCT ([TCT] = 0.023 mM). (F) Injection of rPGRP-
LB blocked Dpt expression in PGRP-LB RNAi flies fed with TCT. Dpt
expression was monitored in wild-type orPGRP-LBRNAi flies fed 12
hr with TCT ([TCT] = 0.023 mM). Water (23 nl) or rPGRP-LB ([rPGRP-
LB] = 1 mg.ml21) was injected in the hemolymph of flies 3 hr prior
feeding with TCT. (G) Injection of rPGRP-LB blocked Dpt expression
in wild-type flies after oral infection with P. entomophila. Analysis
was performed on wild-type females collected 6 hr after oral infec-The experiment illustrated in Figure 5D demonstrates
that DAP-type PGN from Bacillus species failed to in-
duce the Imd pathway in contrast to DAP-type PGN
from gram-negative bacteria. Distinctions between
these two types of PGN are the absence of an anhydro
bond at the extremity of glycan strands and the pres-
ence of amidated DAP in Bacillus PGN. This observation
raised the possibility that the elicitor of this systemic re-
sponse may be small PGN fragments containing the TCT
motif. To address this question, we monitored Dpt gene
expression in PGRP-LB RNAi and wild-type flies fed
with PGN digested with SltY. SltY is a bacterial transgly-
cosylase that cleaves the b-1,4 bond between MurNAc
and GlcNAc in glycan strands to generate muropeptides,
similar to a muramidase treatment. However, unlike mur-
amidase, SltY cleavage also results in the formation of an
internal 1,6-anhydro bond in the cleaved MurNAc resi-
due as present in TCT. Figure 6A shows that PGN treated
with SltY was a more potent inducer of Dpt that PGN
digested with muramidase. In agreement with this obser-
vation, Figures 6B and 6C show that ingestion of a con-
centrated solution of TCT induced an extremely potent
systemic immune response in PGRP-LB RNAi flies in a
dose-dependent manner. The level of induction was
6-fold higher than the level obtained by PGN feeding
and similar to that of flies subjected to direct injection
of bacteria. Interestingly, a weak induction of Dpt was
also observed in wild-type flies when fed for a prolonged
period with a concentrated solution of TCT. In addition,
Dpt was not induced in PGRP-LC/LB double RNAi flies,
indicating that the systemic expression of Dpt induced
by ingestion of TCT requires PGRP-LC (Figure 6D). The
results above indicate that both oligomerization state
and presence of the anhydro bound influence the
immuno-stimulatory effect of PGN.
In contrast to polymeric PGN, TCT is a small molecule
that may easily cross the gut barrier. Transfer of TCT
from the gut lumen to the hemolymph could then lead
to activation of a systemic immune response by inter-
acting with PGRP-LC at the surface of the fat body. Al-
ternatively, TCT could interact directly with gut epithelial
cells, which would subsequently send a signaling mole-
cule to the fat body. According to the second hypothe-
sis, PGRP-LB would be required only in the digestive
tract to hydrolyze ingested TCT and prevent activation
of gut cells. To distinguish between these two hypothe-
ses, we determined in which tissues PGRP-LB was re-
quired by using gut (NP1-GAL4), fat body (c564-GAL4,
ppl-GAL4), or hemocyte (pxn-GAL4) drivers to specifi-
cally extinguish PGRP-LB in these tissues. In addition
to their strong expression in the fat body, both c564-
GAL4 and ppl-GAL4 weakly expressed GAL4 in some
sections of the gut and Malpighian tubules (data not
shown). The inactivation of PGRP-LB by NP1-GAL4,
c564-GAL4, or ppl-GAL4 resulted in a modest Dpt ex-
pression after ingestion of TCT, while no effect was
tion byP. entomophila. rPGRP-LB (23 nl) ([rPGRP-LB] = 1 mg.ml21)
was injected into wild-type flies 3 hr prior oral infection by P. ento-
mophila. Dpt expression was monitored by RT-qPCR with RNA ex-
tracts from whole flies. The levels measured in these experiments
corresponded to systemic expression of Dpt by the fat body, since
the contribution of gut to Dpt expression is negligible. Repeats and
statistics for experiments described in (C), (F), and (G) are provided
in Figure S5.
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Figure 6E shows that inactivation of PGRP-LB in both
gut and fat body using NP1-GAL4 together with c564-
GAL4 reproduced the immune phenotype observed
with the ubiquitous driver da-GAL4. Collectively, this
analysis reveals that flies become fully responsive to in-
gestion of TCT only when PGRP-LB is depleted in both
gut and fat body. Hence, expression of PGRP-LB in ei-
ther the gut or the fat body is sufficient to limit the sys-
temic expression of Dpt after ingestion of TCT. To con-
firm that PGRP-LB is also required in the hemolymph,
we performed a rescue experiment by injecting re-
combinant PGRP-LB into the body cavity of PGRP-LB
RNAi flies. Figure 6F shows that injection of PGRP-LB
into the hemolymph prevented Dpt induction after in-
gestion of TCT. Since the only known function of
PGRP-LB is to hydrolyze PGN, we conclude that the
systemic immune response induced by TCT ingestion
is mediated by transfer of this muropeptide from the
gut lumen to the hemolymph.
To test a possible role of PGN transfer in a more phys-
iological condition, we next monitoredDpt expression in
wild-type flies orally infected by P. entomophila after
a prior injection of PGRP-LB into the hemolymph. Fig-
ure 6G shows that injection of PGRP-LB prevented
Dpt induction after oral P. entomophila infection, indi-
cating that transfer of PGN is the basis ofP. entomophila
capacity to trigger a systemic response.
Discussion
PGRPs are conserved in both vertebrates and insects,
and combined genetic and biochemical approaches
have suggested that they play various roles in immunity
linked to their capacity to bind PGN. Noncatalytic
PGRPs have been implicated as sensors of bacterial
infection, initiating host defenses in insects. PGRP-S,
a noncatalytic PGRP present in the neutrophil granules
of mammals, has antibacterial activity (Cho et al.,
2005; Dziarski et al., 2003). To date, the actual physio-
logical role of catalytic PGRPs has not been identified
in vivo, although their amidase activity has led to the hy-
pothesis that they could modulate the immune response
by scavenging PGN (Mellroth et al., 2003). Out of the four
mammalian PGRPs, only PGRP-L, a secreted protein
circulating in the serum, has amidase activity (Dziarski,
2004). The absence of an immune phenotype of PGRP-L
deficient mice did not provide an indication as to its
precise role (Xu et al., 2004). The present study is the first
report that demonstrates the contribution of an amidase
PGRP to the host defense in vivo. We show that PGRP-
LB specifically controls the level of Imd pathway activity
in Drosophila. Our observations that PGRP-LB is se-
creted and scavenges DAP-type PGN in vitro and in
vivo strongly suggest that PGRP-LB reduces the Imd
pathway by degrading PGN. Although the Drosophila
genome encodes four other catalytic PGRPs, the phe-
notype induced by PGRP-LB RNAi in flies suggests
the absence of functional redundancy between them.
However, it is probable that other catalytic PGRPs act
together with PGRP-LB in different tissues and/or devel-
opmental stages. Indicative of this possibility is the re-
sidual amidase activity detected in the hemolymph of
PGRP-LB RNAi flies. In addition, RNAi extinction ofPGRP-SC1/2 leads to a higher Dpt expression after in-
jection but not after oral ingestion of PGN in adults
(our unpublished data). We assume that combination
of inducible (PGRP-LB) or constitutive (PGRP-SC)
PGRPs would ensure an adequate level of immune reac-
tivity of each fly tissue. In addition, the high specificity of
PGRP-LB toward DAP-type PGN suggests that other
amidases with activity against lysine-type PGN may
modulate the response to gram-positive bacteria up-
stream of the Toll pathway. Analyzing the contribution
of each of these catalytic PGRPs is now essential to un-
derstand the regulation of the fly immune response.
Adjustment of Immune Response to Bacterial Load
through a Negative Feedback
Our data suggest that the level of immune response to
gram-negative bacteria involves a balance between
PGN sensing by recognition PGRPs and PGN degrada-
tion by amidase PGRPs. The basal level of PGRP-LB
would determine a threshold below which the immune
response is not induced. Furthermore, our study shows
that PGRP-LB is transcriptionaly regulated by the Imd/
PGRP-LC pathway. Bacterial infection induced a rapid
increase of PGRP-LB that resulted in higher amidase ac-
tivity, effectively blocking the activation of PGRP-LC by
PGN. This negative feedback loop, illustrated in Figure 7,
would ensure an appropriate level of immune activation
in response to bacterial infection. This mechanism pro-
vides a good explanation for why infection by nonpatho-
genic bacteria only induces a transient induction of the
Imd pathway. This pathway would be activated only in
the case of severe infection, when bacterial proliferation
overcomes the scavenging capacity of PGRP-LB. This
negative control provides a sensitive mechanism by
which the immune response is repressed once bacteria
are under control and not simply following their com-
plete elimination. This mechanism economizes host re-
sources by anticipating the termination of the immune
response and may also prevent potentially severe con-
sequences to host tissues through prolonged immune
activity. The observation that overexpression of imd re-
sults in cell death by apoptosis indicates that high Imd
activity is deleterious to the fly (Georgel et al., 2001). In
this context, the PGN scavenger function of PGRP-LB
could limit the noxious effect of excessive Imd pathway
activation in a manner reminiscent of the mechanisms
that detoxify LPS in vertebrates. It is possible that in
mammals, the amidase PGRP-L may downregulate the
immune response by scavenging PGN present in the
serum in a way similar to PGRP-LB in Drosophila.
PGRP-LB Prevents Local Immune Activation
by Gut Bacteria
Considering that the molecular motifs that activate the
innate immune response are present in both commensal
and pathogenic microorganisms, it is important to un-
derstand why commensal microorganisms do not gen-
erate a state of permanent intestinal immune activation
(Sansonetti, 2004). Our study reveals a central role for
amidase PGRPs in bacterial tolerance at epithelium sur-
faces of Drosophila.
We show for the first time that the activation of the Imd
pathway in the gut is mediated upon sensing of DAP-
type PGN by PGRP-LC. This observation is, at first sight,
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471intriguing, since DAP-type PGN is found in all gram-neg-
ative bacteria, including those present in the alimentary
canal. However, our study shows that local Imd immune
activation in trachea and gut by resident bacteria is pre-
vented by PGRP-LB. This is illustrated by our observa-
tion that AMP genes are upregulated in these tissues
in PGRP-LB RNAi but not in wild-type flies grown under
normal rearing conditions. An important role of PGRP-
LB in the gut is also supported by our immunoblot anal-
ysis showing that PGRP-LB is expressed in this tissue
and is regulated by the Imd pathway. Although epithelia
are in contact with PGN ingested with the food or re-
leased by the bacterial flora, our data indicate that the
mechanisms that regulate the local activation of Imd in
these tissues are similar to those previously described
for the systemic immune response (Figure 7). There
are two main reasons that might explain how a single
sensing mechanism permits the differentiation between
bacteria of the natural flora and potentially pathogenic
microorganisms. First, the feedback loop at the level
of PGRP-LB, discussed above, prevents immune reac-
tion except when the scavenger capacity of PGRP-LB
is overcome by bacterial proliferation. A low level of
Imd pathway activity is probably induced in the gut by
resident bacteria, resulting in the synthesis of both
PGRP-LB and antimicrobial factors that together main-
Figure 7. A Model of Imd Pathway Activation by Gram-Negative
Bacteria
During bacterial infection, the presence of actively dividing gram-
negative bacterial cells results in the release of PGN fragments
that overcome the scavenger capacity of PGRP-LB, thus provoking
an induction of the Imd pathway through PGRP-LC. Concomitant in-
ductions of AMP genes and of PGRP-LB result in the reestablish-
ment of an equilibrium by active destruction of bacteria by AMPs
and an increase in free circulating PGRP-LB protein and consequent
elimination of immune activating PGN. This model is based on our
observations that PGRP-LB (1) is induced by the Imd pathway, (2)
scavenges gram-negative PGN, and (3) downregulates the Imd
pathway.tain control of both the immune system and the micro-
bial flora. This basal level of immune activation would
be surpassed only when invading bacteria multiply in
the gut. The second reason is that gram-negative PGN
is a cell wall component hidden in the periplasmic space
underneath the outer membrane of LPS. PGN fragments
are released from bacteria as a consequence of PGN
structure remodeling occurring during cell growth and
division. Therefore, recognition of released PGN allows
the direct measurement of bacterial proliferation rather
than the detection of total bacterial load. It is probable
that most gram-negative bacteria residing in the gut
have a low division rate and therefore release low levels
of PGN that can be hydrolyzed by amidase PGRPs.
Our study shows that PGRP-LB amidase plays an
important role in epithelia by determining the immune
reactivity of the host to environmental bacteria. The im-
mune regulation by PGRP-LB provides a flexible mech-
anism for an immediate adaptation of flies in various
ecological niches that are either poor or enriched in mi-
crobes, thereby ensuring an immune response primarily
tailored to bacterial proliferation.
PGN Is the Mediator between Gut Infection
and Fat Body Immune Response
Some bacterial species are able to trigger a strong sys-
temic immune response in Drosophila after oral infec-
tion, indicating the presence of an as-yet-unidentified
signaling pathway from the gut to the fat body. This im-
mune reaction correlates with the capacity of these bac-
terial species to persist and multiply inside the gut
and does not appear to rely upon physical crossing of
the gut wall (Vodovar et al., 2005). The analysis of the
PGRP-LB RNAi phenotype reveals new insights in the
nature of this process. Our study shows that PGRP-LB
RNAi, but not wild-type flies, activate a systemic im-
mune response after ingestion of nonpathogenic bacte-
ria or DAP-type PGN. This is consistent with the above
discussion that PGRP-LB establishes a threshold below
which no immune response is triggered. Moreover, our
study provides strong evidence that this systemic im-
mune response is mediated by the translocation of small
PGN fragments from the gut lumen to the hemolymph.
We first observed that ingestion of muramidase-treated
PGN induces a higher systemic immune response than
polymeric PGN, consistent with the idea that small mol-
ecules cross the gut barrier easier than large molecules.
Furthermore, injection of purified PGRP-LB into the he-
molymph of PGRP-LB RNAi flies prevents the induction
of a systemic immune response following TCT ingestion.
This result can only be explained by the presence of im-
munologically active TCT in the hemolymph that is hy-
drolyzed and thus inactivated by PGRP-LB. Collectively,
our data suggest a model in which bacterial persistence
in the gut leads to a local increase of DAP-type PGN
fragments small enough to cross the intestinal epithe-
lium and activate PGRP-LC at the surface of fat body
cells. Production of small PGN fragments could be am-
plified through the action of gut lysozymes (Daffre et al.,
1994) that, by contrast to amidase PGRPs, can cleave
PGN into small fragments that retain their immune activ-
ity as shown in our study. Importantly, transfer of PGN
provides an indirect mechanism for recognition of
gram-negative bacteria that does not require a physical
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late that, under the pressure of recurrent gram-negative
oral infections, transport of PGN into the hemolymph
has evolved as a proper signal to anticipate possible
breaching of the gut barrier. Such a mechanism gives
a biological sense to the existence of PGRP-LC isoforms
specifically devoted to the detection of monomeric PGN
(Kaneko et al., 2004; Mellroth et al., 2005). It is interesting
to note that gram-positive bacteria or fungi that induce
the Toll pathway are recognized by molecules exposed
at their cell surface, while gram-negative bacteria have
their ligands hidden under an LPS layer. This difference
between direct or indirect sensing could explain the dif-
ference in organization between the Toll pathway, which
is activated by secreted sensors (e.g., PGRP-SA, -SD,
and GNBP-1) and the Imd pathway, which is activated
by recognition receptors present at the surface of the
fat body.
Furthermore, the threshold level of immune sensitivity
to PGN imposed by PGRP-LB would explain in part the
apparent oral nonresponsiveness of Drosophila to most
ingested bacteria since they normally do not persist in
the gut. Determining the nature of the transport mecha-
nism, facilitated or passive, and the identity of epithelial
cells involved in PGN translocation will be a future chal-
lenge.
Conclusions
The present study demonstrates how a simple recogni-
tion mechanism based on a competition between sens-
ing and degradation of bacterial elicitors can be de-
ployed under three distinct situations involving either
systemic, local, or dual immune activation. The data
demonstrate a key role for PGN and associated degra-
dation products for bacterial recognition by flies. The
specific differences in structure between gram-positive
and gram-negative PGN, combined with host enzymes
including lysozymes and amidases, permit the subtle
discrimination between microorganisms and relative
quantification of bacterial proliferation. It is perhaps
not surprising that PGRP and NOD proteins, in flies
and vertebrates, respectively, use this complex polymer
to dynamically anticipate and modulate interactions
with native commensals and potentially pathogenic mi-
crobial flora.
Experimental Procedures
Fly Stocks
OregonR flies or flies carrying one copy of daughterless (da)-GAL4
were used as wild-type controls. RNAi transgenic fly lines of
PGRP-LB or PGRP-LC were obtained using an inducible in vivo
RNAi approach. A cDNA fragment corresponding to the first 500
bp of the coding sequence was amplified by PCR and inserted as
an inverted repeat (IR) in a modified pUAST transformation vector,
pUAST-R57 (Leulier et al., 2002). Each experiment was repeated us-
ing two independent UAS-PGRP-LB IR insertions. In the present
study, we used larvae and adult flies carrying one copy of the
UAS-RNAi construct combined with one copy of theGAL4 driver ex-
cept in Figure 6C in which two UAS-PGRP-LB IR insertions were
combined with oneGAL4 driver. The pumpless (ppl) and peroxidasin
(pxn) GAL4 drivers are described in Stramer et al. (2005) and Zinke
et al. (2002). A recombinant line carrying both the da-GAL4 driver
and the PGRP-LB IR construct was used to obtain PGRP-LB,
PGRP-LC double RNAi flies. Drosophila stocks were maintained at
25ºC using standard fly medium. The F1 progeny carrying both thePGRP-LB IR and theGAL4 driver were transferred to 29ºC at late pu-
pal stage for optimal GAL4 efficiency. The transgenic strains Dpt-
lacZ, Dpt-GFP, and Drs-GFP were previously described (Tzou
et al., 2000). PGRP-LCE12, spzrm7, RelE20, and TAK11 alleles are
null mutations in spz, PGRP-LC, TAK1, and Relish, respectively
(Leulier et al., 2003).
Bacterial Strains and Infection Experiments
P. entomophila is an entomopathogenic bacteria that can trigger
a systemic immune response after oral infection in both larvae and
adults (Vodovar et al., 2005). E. carotovora is a gram-negative bac-
terium that induces a systemic immune response after oral infection
in larvae but not in adults (Basset et al., 2000). Bacterial infections
were performed by pricking adults in the thorax with a thin needle
previously dipped into a concentrated pellet of a bacterial culture
(OD = 200). For oral infection, flies were first incubated 2 hr at 29ºC
in an empty vial and then placed in a fly vial with food solution.
The food solution was obtained by mixing a pellet of an overnight
culture of bacteria, PGN (5 mg/ml) or TCT (0.046 mM) with a solution
of 5% sucrose (50/50) and added to a filter disk that completely cov-
ered the agar surface of the fly vial. For injection, 9.2 nL of solution
water, PGN (5 mg.ml21), TCT (0.46 mM), or 23 nl recombinant
PGRP-LB (1 mg.ml21) was injected into the thorax of female adults
(3–4 days old) using a Nanoject apparatus (Drummond).
Additional Experimental Protocols
For purification of PGN and muropeptides, assay for amidase activ-
ity in fly hemolymph, assay for N-acetylmuramoyl-L-alanine ami-
dase activity, Western blot analysis, and quantitative real-time
PCR (RT-qPCR), see Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, and five figures and can be found with
this article online at http://www.immunity.com/cgi/content/full/24/
4/463/DC1/.
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